Prime Medicine Shares Jump on FDA Clearance for Investigational New Drug Application

By Elias SchisgallShares of Prime Medicine jumped after the biotechnology company said the Food and Drug Administration cleared its investigational new drug application for PM647 to treat the genetic disease Alpha-1 Antitrypsin Deficiency.Shares were up 13% to $3.47 in after-hours trading on Thursd…